RIGEL PHARMACEUTICALS INC (RIGL)
US7665597024 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 149.2M 37.38% | 120.2M -19.44% | 116.882M -2.76% | 172.49M 47.58% | 197.38M 14.43% | 230.65M 16.86% | 254.54M 10.36% | 278.58M 9.44% | 301.73M 8.31% | 324.74M 7.63% | 292.64M -9.88% | |
| EBITDA YoY % growth | -7.84M 72.29% | -53.3M -579.85% | -19.253M 63.88% | 13.152M 168.31% | 28.556M 117.12% | 57.82M 102.48% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9M 68.97% | -54.3M -503.33% | -20.491M 62.26% | 9.343M 145.60% | 22.491M 140.73% | 42.004M 86.76% | 50.225M 19.57% | 55.312M 10.13% | 62.744M 13.44% | 78.063M 24.42% | 4.59M -94.12% | |
| Operating Margin | -6.03% | -45.17% | -17.53% | 5.42% | 11.39% | 18.21% | 19.73% | 19.85% | 20.79% | 24.04% | 1.57% | |
| EPS YoY % growth | -1.10 31.25% | -3.40 -209.09% | -1.50 55.88% | 0.29 119.54% | 1.00 240.09% | 1.95 95.91% | 1.92 -1.79% | 1.83 -4.79% | 1.78 -2.51% | 2.21 24.07% | 0.20 -90.76% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.31 | 0.17 134.68% | 0.27 550.50% | 0.20 -70.86% | 0.16 -46.52% |
| Revenue Q2Q % growth | 48.374M 35.15% | 44.365M 50.22% | 48.037M 30.39% | 50.607M -8.50% | 51.847M 7.18% |
| EBITDA Q2Q % growth | 4.826M 50.62% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.731M 191.51% | 3.721M 153.42% | 5.693M 1,173.60% | 4.856M -65.45% | 4.011M -30.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.70 333.33% | 0.06 | 0.64 | 1,076.54% |
| Q2 2024 Q2Q % growth | -0.06 85.00% | -0.30 | 0.24 | 79.85% |
| Q1 2024 Q2Q % growth | -0.50 37.50% | -0.29 | -0.21 | -70.03% |
| Q4 2023 Q2Q % growth | 0.00 -100.00% | -0.31 | 0.31 | 100.00% |
| Q3 2023 Q2Q % growth | -0.30 72.73% | -0.72 | 0.42 | 58.57% |
| Q2 2023 Q2Q % growth | -0.40 50.00% | -0.80 | 0.40 | 49.72% |
| Q1 2023 Q2Q % growth | -0.80 50.00% | -0.99 | 0.19 | 19.56% |
| Q4 2022 Q2Q % growth | 0.10 107.69% | -1.14 | 1.24 | 108.74% |
| Q3 2022 Q2Q % growth | -1.10 8.33% | -1.37 | 0.27 | 19.78% |
| Q2 2022 Q2Q % growth | -0.80 | -1.25 | 0.45 | 36.08% |
| Q1 2022 Q2Q % growth | -1.60 -172.73% | -1.40 | -0.20 | -14.26% |
| Q4 2021 Q2Q % growth | -1.30 -18.18% | -1.30 | 0.00 | 0.17% |
| Q3 2021 Q2Q % growth | -1.20 -50.00% | -1.02 | -0.18 | -18.04% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -1.17 | 0.37 | 31.40% |
| Q1 2021 Q2Q % growth | 2.20 69.23% | 0.05 | 2.15 | 4,365.55% |
| Q4 2020 Q2Q % growth | -1.10 -10.00% | -1.16 | 0.06 | 5.13% |
| Q3 2020 Q2Q % growth | -0.80 -14.29% | -1.24 | 0.44 | 35.56% |
| Q2 2020 Q2Q % growth | -1.00 16.67% | -1.36 | 0.36 | 26.52% |
| Q1 2020 Q2Q % growth | 1.30 218.18% | 1.34 | -0.04 | -3.13% |
| Q4 2019 Q2Q % growth | -1.00 | -0.83 | -0.17 | -20.83% |
| Q3 2019 Q2Q % growth | -0.70 | -1.12 | 0.42 | 37.69% |
| Q2 2019 Q2Q % growth | -1.20 | -1.39 | 0.19 | 13.49% |
| Q1 2019 Q2Q % growth | -1.10 | -1.36 | 0.26 | 18.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 55.307M 96.58% | 42.766M | 12.541M | 29.32% |
| Q2 2024 Q2Q % growth | 36.841M 37.03% | 34.088M | 2.753M | 8.08% |
| Q1 2024 Q2Q % growth | 29.534M 13.29% | 31.91M | -2.376M | -7.45% |
| Q4 2023 Q2Q % growth | 35.792M -30.20% | 34.784M | 1.008M | 2.90% |
| Q3 2023 Q2Q % growth | 28.134M 25.54% | 27.745M | 389K | 1.40% |
| Q2 2023 Q2Q % growth | 26.886M -9.84% | 26.218M | 668K | 2.55% |
| Q1 2023 Q2Q % growth | 26.07M 55.73% | 24.554M | 1.516M | 6.17% |
| Q4 2022 Q2Q % growth | 51.28M 151.25% | 28.527M | 22.753M | 79.76% |
| Q3 2022 Q2Q % growth | 22.41M 4.04% | 23.062M | -652K | -2.83% |
| Q2 2022 Q2Q % growth | 29.82M 13.51% | 24.128M | 5.692M | 23.59% |
| Q1 2022 Q2Q % growth | 16.74M -79.34% | 17.895M | -1.155M | -6.45% |
| Q4 2021 Q2Q % growth | 20.41M 10.62% | 22.337M | -1.927M | -8.63% |
| Q3 2021 Q2Q % growth | 21.54M 17.13% | 24.033M | -2.493M | -10.37% |
| Q2 2021 Q2Q % growth | 26.27M 63.98% | 20.777M | 5.493M | 26.44% |
| Q1 2021 Q2Q % growth | 81.02M 45.30% | 31.672M | 49.348M | 155.81% |
| Q4 2020 Q2Q % growth | 18.45M 19.81% | 18.463M | -13K | -0.07% |
| Q3 2020 Q2Q % growth | 18.39M -11.84% | 17.58M | 810K | 4.61% |
| Q2 2020 Q2Q % growth | 16.02M 53.89% | 14.024M | 1.996M | 14.23% |
| Q1 2020 Q2Q % growth | 55.76M 341.84% | 57.841M | -2.081M | -3.60% |
| Q4 2019 Q2Q % growth | 15.4M | 15.969M | -569K | -3.56% |
| Q3 2019 Q2Q % growth | 20.86M | 16.708M | 4.152M | 24.85% |
| Q2 2019 Q2Q % growth | 10.41M | 9.467M | 943K | 9.96% |
| Q1 2019 Q2Q % growth | 12.62M | 11.602M | 1.018M | 8.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1921.42% | 0% | 182.17% |
| Revenue | 0% | 2.34% | 0% | 7.75% |